Peripheral Angioplasty Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.MOTIV BTK Randomized Controlled Trial
Condition: Critical Limb Ischemia Interventions: Device: MOTIV Sirolimus-Eluting Bioresorbable Scaffold; Device: Percutaneous Transluminal Angioplasty (PTA) Device Sponsor: REVA Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials
